Naturex acquires Decas Botanical Synergies ( 19/09/2012 )


Avignon, 19th September 2012 – Naturex acquires1 Decas Botanical Synergies, the US expert in cranberry-derived ingredients for the Nutrition and Health industry. 


Decas Botanical Synergies is an American company located in Massachusetts, specialized in Cranberry extracts and powders for the nutraceuticals (tablets, capsules, soft gels, soft chews etc.). Cultivated in North America, the Cranberry is increasingly popular as it is well-known for its ability to reduce Urinary Tract Infections (UTIs).

 

Capturing all the benefits of Cranberry

 UTIs are the second most common type of infection in the body, accounting for about 8.1 million visits to US health care providers each year2. Produced from superior grade Cranberry, Decas Botanical Synergies ingredients comprehensive portfolio includes Proanthocyanidin (PAC) standardized powders and extracts, as well as juice concentrate powders and cold pressed seed oils. The flagship brand PACran® is supported by two clinical studies, six US and three international patents. A proprietary blend of the whole fruit, PACran® delivers the entire spectrum of the Cranberry. In addition, PACran® is the first Cranberry ingredient in the World to receive a Health Claim (in Korea), and can be labeled in the US market “PACran® helps support urinary tract health”.

 

Expanding Science and customers reach

Decas Botanical Synergies portfolio and team of cranberry experts will benefit from our capabilities in terms of R&D and Quality Control. It will definitely enhance our innovative products pipeline. Manufactured by our factories, we will ensure their consistent supply in Europe, Africa, the Americas and Asia through our worldwide sales network. Our aim is to pursue and accelerate the development of this portfolio perfectly in line with consumer demand for healthy, safe and convenient products – and meeting our customer’s needs with innovative and ready-to-use ingredients.
 
"We are delighted to welcome the Decas Botanical Synergies team into our Group. This operation allows us to become the leader in Cranberry extracts and is an excellent opportunity to strengthen our position in the development and sales of technical solutions with high-value added offerings for our customers” declared Thierry LAMBERT, the Group's Vice-President and Chief Executive Officer. Doug KLAIBER, CEO of Decas Botanical Synergies, added: "We are very pleased to join the Naturex Group and we look forward to playing an active role in this new organisation. The expertise of Naturex's scientific teams combined with the strength of its sales network will allow us to accelerate the development of our innovative and clinically substantiated product range, through a differentiating offering."

 

 

1. Acquisition by Naturex of 95% of the capital of Decas Botanical Synergies(DBS); the remaining 5% is held by Doug Klaiber, C.E.O. of DBS.
2. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. US National health statistics reports; no 8. Hyattsville, MD: National Center for Health Statistics; 2008.


About Decas Botanical Synergies (DBS)        
Headquartered in Carver, Massachusetts, Decas Botanical Synergies (DBS), is a developer, manufacturer and marketer of proprietary, value-added cranberry-derived ingredients for the dietary supplement, functional foods, animal feed and nutrition, personal care and cosmetics, and oral health industries.  For additional information, please visit www.decasbotanical.com   

About Naturex:
Naturex manufactures natural speciality ingredients for the Food & Beverage, Nutrition & Health and Personal Care industries. Headquartered in France, Naturex employs 1300 people and has 15 production units located in Europe (France, Italy, Spain, Switzerland, Poland and England), the United States (New Jersey and California), Brazil, Australia, Morocco and India. In addition, the group has several sales offices worldwide. For additional information, please visit www.naturex.com

 

Your contacts at Naturex:

Antoine DAUBY

Group Marketing Director

Tel: +334 90 23 96 89

a.dauby@naturex.com

 

Thierry LAMBERT

Vice-President and C.E.O.

naturex@naturex.com

1.Acquisition by Naturex of 95% of the capital of Decas Botanical Synergies(DBS); the remaining 5% is held by Doug Klaiber, C.E.O. of DBS.
2. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. US National health statistics reports; no 8. Hyattsville, MD: National Center for Health Statistics; 2008.

Retour